The paradox of anti-inflammatory drugs
New data suggest that an alternative mode of action may be at play for NSAIDs
Bill Thelin will discuss how intestine-on-a chip technology reliably models gastrointestinal disease and assists researchers in screening for safe, effective therapeutic candidates.
Data show that OSE-230 can resolve chronic inflammation